Seventy percent of astronauts who have spent between six and twelve months aboard the International Space Station (ISS) have experienced significant vision changes due to a condition known as spaceflight-associated neuro-ocular syndrome (SANS). As space agencies set their sights on long-term missions to Mars, understanding and mitigating the effects of this syndrome is becoming a top priority for ensuring astronaut health and mission success.
What is SANS?
SANS is a condition that arises from fluid shifts in microgravity, causing pressure on the brain and eyes. This leads to a range of ocular changes, including:
🔴 Swelling of the optic nerve
🔴 Flattening at the back of the eye
🔴 General vision impairment
While most astronauts recover once they return to Earth, the long-term effects of prolonged space travel remain unclear—a major concern for multi-year Mars missions.
The Origins of SANS: A Long-Standing Challenge
SANS was first observed in Russian cosmonauts aboard the Mir space station, though it was not officially identified until 2011, when NASA classified it as a distinct ocular and neurological syndrome.
The primary suspected cause of SANS is the shift of bodily fluids toward the head in microgravity, but other factors may contribute, including:
✔ Hemodynamic fluid shifts (changes in blood flow)
✔ Elevated carbon dioxide (CO₂) exposure
✔ Exercise in microgravity conditions
New Research: How Space Affects Eye Biomechanics
A recent study led by Santiago Costantino at the Université de Montréal analyzed 13 astronauts who spent five to six months aboard the ISS. The study measured three key eye properties before and after spaceflight:
📌 Ocular rigidity (stiffness of eye tissue)
📌 Intraocular pressure (fluid pressure inside the eye)
📌 Ocular pulse amplitude (pressure variations with each heartbeat)
Key Findings:
🔹 33% decrease in ocular rigidity
🔹 11% drop in intraocular pressure
🔹 25% reduction in ocular pulse amplitude
🔹 Five astronauts had abnormal choroidal thickness (over 400 micrometers)
Interestingly, these changes were unrelated to age, gender, or prior spaceflight experience, meaning all astronauts may be at risk regardless of their background.
What This Means for Future Mars Missions
SANS poses a serious risk for deep-space travelers. With a Mars mission lasting two to three years, astronauts will spend months in microgravity and may experience permanent vision loss if countermeasures aren’t developed.
Potential solutions include:
🟢 Pharmaceutical interventions to regulate intraocular pressure
🟢 Nutritional strategies to strengthen ocular tissue
🟢 Negative pressure devices that draw fluids away from the head
The Path Forward
NASA and international space agencies are racing to develop solutions to protect astronauts from irreversible vision damage. Identifying biomarkers for SANS could allow scientists to predict which astronauts are most at risk, before vision problems occur in space.
As the dream of reaching Mars comes closer to reality, solving SANS will be a crucial step in ensuring that astronauts can see their journey all the way to the Red Planet—and back. 🚀👁🌍
